This inventor holds 1 USPTO granted patent. Top assignee: Predictably Human, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael Detienne: Innovator in Drug Delivery Systems
Introduction
Michael Detienne is a notable inventor based in New York, NY (US). He has made significant contributions to the field of drug delivery systems, particularly focusing on electronic methods for administering medication. His innovative approach aims to enhance treatment programs, such as smoking cessation.
Latest Patents
Detienne holds a patent for a drug delivery system that includes devices and methods designed for effective treatment. The patent, titled "Systems and methods of an electronic drug delivery system for use in a treatment program," outlines a sophisticated delivery system that integrates a mobile platform with a hand-held inhalation device. This device features a controller circuit linked to a power source, sensors, aerosolizer drivers, and a rescue button. The system generates an aerosol mixture from substances in a pod, tailored to the user's treatment program. The controller circuit dynamically manages the aerosolizer drivers to create customized aerosol mixtures, allowing for various percentages of substances and different droplet sizes throughout the treatment.
Career Highlights
Detienne is currently employed at Predictably Human, Inc., where he continues to develop innovative solutions in drug delivery. His work is characterized by a commitment to improving patient outcomes through technology.
Collaborations
Some of his notable coworkers include Robert Francis Jacobs, Jr. and J. Robert Geiman. Their collaborative efforts contribute to the advancement of drug delivery technologies.
Conclusion
Michael Detienne's work in drug delivery systems exemplifies the intersection of technology and healthcare. His innovative solutions are paving the way for more effective treatment programs, ultimately benefiting patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile